DPI and CDC To Invest USD200m in KELIX Bio to Support the Acquisition of Morocco’s Pharmaceutical Institute

Source(s): New Business Ethiopia

DPI and CDC Group agreed to invest USD200m in KELIX Bio to fund the acquisition of Pharmaceutical Institute, a producer and distributor of generic and therapeutic pharmaceuticals headquartered in Morocco. Read more